Hervé Curé
Impact in
- Geriatrics and Gerontology top 2%
- Frailty in Older Adults
- Oncology top 2%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Lung Cancer Research Studies
Papers in
- Oncology 39
- Cancer Treatment and Pharmacology 18
- HER2/EGFR in Cancer Research 13
- Cancer Cells and Metastasis 3
-
- Breast Cancer Treatment Studies 18
- Co-authors
- P. Chollet (19 shared papers)Marianne Leheurteur (5 shared papers)Thomas Bachelot (2 shared papers)Jean‐Yves Pierga (3 shared papers)Anthony Gonçalvès (3 shared papers)Marta Jimenez (1 shared paper)Émilie Le Rhun (1 shared paper)Julien Dômont (1 shared paper)
- Journals
- Breast Cancer Research and Treatment (5 papers)The Oncologist (4 papers)Clinical Breast Cancer (3 papers)Cancer (2 papers)Oncology (2 papers)
- Partner nations
- FranceUnited StatesSouth Korea
In The Last Decade
Hervé Curé
52 papers receiving 2.2k citations
Hervé Curé's Hit Papers
Peers
Comparison fields: 5 of 108
- Geriatrics and Gerontology 222
- Oncology 1.3k
- Cancer Research 510
- Genetics 342
- Pulmonary and Respiratory Medicine 827
Countries citing papers authored by Hervé Curé
This map shows the geographic impact of Hervé Curé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hervé Curé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hervé Curé more than expected).
Fields of papers citing papers by Hervé Curé
This network shows the impact of papers produced by Hervé Curé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hervé Curé. The network helps show where Hervé Curé may publish in the future.
Co-authors
The 25 scholars most cited alongside Hervé Curé, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Lapatinib plus capecitabine in patients with previously untreated brain metastases from HER2-positive metastatic breast cancer (LANDSCAPE): a single-group phase 2 study Hit paper breakdown → | 2012 | 522 |
| 2 | Screening for Vulnerability in Older Cancer Patients: The ONCODAGE Prospective Multicenter Cohort Study Hit paper breakdown → | 2014 | 368 |
| 3 | 2007 | 174 | |
| 4 | 1994 | 148 | |
| 5 | 2013 | 113 | |
| 6 | 2016 | 112 | |
| 7 | 2013 | 104 | |
| 8 | 2005 | 84 | |
| 9 | 2007 | 76 | |
| 10 | 2002 | 54 | |
| 11 | 2006 | 47 | |
| 12 | 2004 | 40 | |
| 13 | 2006 | 39 | |
| 14 | 2008 | 39 | |
| 15 | 2007 | 32 | |
| 16 | Assessment of circadian rhythms by actimetry in healthy subjects and patients with advanced colorectal cancer. | 2003 | 27 |
| 17 | 2016 | 27 | |
| 18 | 1990 | 24 | |
| 19 | 2006 | 22 | |
| 20 | 2016 | 20 |
About Hervé Curé
Hervé Curé is a scholar working on Oncology, Cancer Research, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging, having authored 52 papers that have together received 2.3k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (18 papers), Breast Cancer Treatment Studies (18 papers), HER2/EGFR in Cancer Research (13 papers), Breast Lesions and Carcinomas (8 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Brain Metastases and Treatment (4 papers), Cancer Cells and Metastasis (3 papers) and Prostate Cancer Treatment and Research (3 papers). The work is most often cited by research in Geriatrics and Gerontology (222 citations), Oncology (1.3k citations), Cancer Research (510 citations), Genetics (342 citations) and Pulmonary and Respiratory Medicine (827 citations). Hervé Curé has collaborated with scholars based in France, United States and South Korea. Frequent co-authors include P. Chollet, Marianne Leheurteur, Thomas Bachelot, Jean‐Yves Pierga, Anthony Gonçalvès, Marta Jimenez, Émilie Le Rhun, Julien Dômont, Véronique Dièras and Gilles Romieu. Their work appears in journals such as Breast Cancer Research and Treatment, The Oncologist, Clinical Breast Cancer, Cancer and Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.